APA (7th ed.) Citation

Bergman, J., Burman, J., Bergenheim, T., & Svenningsson, A. (2021). Intrathecal treatment trial of rituximab in progressive MS: Results after a 2-year extension. Journal of Neurology, 268(2), 651. https://doi.org/10.1007/s00415-020-10210-0

Chicago Style (17th ed.) Citation

Bergman, Joakim, Joachim Burman, Tommy Bergenheim, and Anders Svenningsson. "Intrathecal Treatment Trial of Rituximab in Progressive MS: Results After a 2-year Extension." Journal of Neurology 268, no. 2 (2021): 651. https://doi.org/10.1007/s00415-020-10210-0.

MLA (9th ed.) Citation

Bergman, Joakim, et al. "Intrathecal Treatment Trial of Rituximab in Progressive MS: Results After a 2-year Extension." Journal of Neurology, vol. 268, no. 2, 2021, p. 651, https://doi.org/10.1007/s00415-020-10210-0.